Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, July 22 at 2:00 PM EDT

Register Free →

(Presolicitation Notice) Intent to Sole Source - BioRad Antibodies

Active
PR-95570Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Department Of Health And Human Services → CDC Office Of Acquisition ServicesView Agency

NAICS

325414 - Biological Product (except Diagnostic) ManufacturingView NAICS

Place of Performance

Atlanta, GA, USA

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhasePresolicitation
Posted

Presolicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → CDC Office Of Acquisition Services
Contacts1 person available
OfficeATLANTA, GA, 30333, USA
Organization / Agency
Department Of Health And Human Services → CDC Office Of Acquisition Services
View Agency Profile
Office AddressATLANTA, GA, 30333, USA
Contacts
Emilio Cibula

Full Description

Show more

NOTICE OF INTENT TO AWARD A SOLE SOURCE ACTION to BIORAD Laboratories, for the acquisition of: BIORAD Antibodies


This procurement action is being conducted under the authority of FAR 12.201-1, Simplified procedures, in accordance with Federal Acquisition Regulation (FAR) Procedures for Evaluation and Solicitation for Commercial Items, in conjunction with the policies and procedures for solicitation, evaluation, and award as prescribed in FAR 12.102 Restricting competition.


This Notice of Intent is not a request for Proposals or Quotations. No solicitation document exists, and no telephone or email inquiries will be accepted. No contract award will be made based on proposals, or quotations received in response to this notice. Interested persons may identify their interest and capability to respond to the requirement and should furnish detailed data concerning their capabilities to provide services sought including pricing data and technical data sufficient to determine that a comparable source to the Government is available. The Government may consider all “Expression of Interest” documentation received no later than 1:00AM ET, 1-AUG-2026. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered for the sole purpose of determining whether to conduct a competitive procurement. Responses to this notice must be emailed to AHR0@cdc.gov. Submitters are responsible for ensuring their email reaches the designated contracting officer on-time.

Similar Contracts

Same NAICS industry code

NAICS: 325414
New
DIBBS
Manufacturing of Intravenous Injection Starter KitsThe contract calls for the full assembly and packaging of sterile intravenous starter kits that include a tourniquet, alcohol pad, adhesive bandage, gauze pad, medical tape, exam gloves, and an antiseptic wipe, all manufactured and packaged to meet stringent military standards. The kits must be rendered sterile and properly sealed to ensure safe use in field and clinical environments, requiring adherence to quality control protocols and regulatory requirements associated with medical device assembly for defense applications. The work involves not only the sourcing and integration of components but also verification of sterility, integrity of packaging, and compliance with documentation and traceability mandates specific to defense medical supply chains. This subcontract opportunity is issued under the NAICS code 325414 for pharmaceutical and medicine manufacturing and was posted on July 16, 2026, with a response deadline of July 22, 2026. The contracting entity is the Medical Supply Chain MD Surg FSF within the Department of Defense, indicating the end user is a military medical logistics unit. The place of performance and specific office details are not specified, but the work is likely to require facilities certified for sterile medical assembly and qualified to supply the Department of Defense. Interested parties must submit proposals through the DIBBS portal by the stated deadline to be considered.
MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

1 day ago

DEADLINE

in 4 days
View Details
NAICS: 325414
New
DIBBS
Manufacture of Burn-Trauma Dressing SheetsThe contract seeks the manufacture of medical-grade non-woven fiber burn-trauma dressing sheets designed to meet strict federal and military standards for use in trauma care settings. The product must adhere to rigorous quality and performance specifications to ensure effectiveness in treating burn injuries under austere and combat conditions, with all units required to comply with applicable defense and medical regulations. Production will be executed under a subcontract arrangement, and the place of performance is designated as APO with the zip code 09094-3219, indicating military deployment or logistical support locations. The NAICS code 325414 confirms the activity falls within pharmaceutical and medicine manufacturing, specifically emphasizing the production of medical textiles and dressings. The solicitation was posted on July 15, 2026, with a response deadline set for July 21, 2026, allowing a short six-day window for qualified subcontractors to submit proposals. The contracting entity is the Medical Supply Chain MD Surg FSF under the Department of Defense, reflecting a direct alignment with military medical readiness objectives. The requirement is part of an effort to maintain a reliable, high-capacity supply chain for critical battlefield medical equipment, ensuring rapid deployment and consistent availability of advanced burn care solutions. There is no set-aside designation specified, meaning open competition is permitted to all eligible vendors meeting the technical and compliance criteria.
MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

3 days ago

DEADLINE

in 3 days
View Details

More opportunities from Department Of Health And Human Services → CDC Office Of Acquisition Services

Same awarding agency

NAICS: 325120
New
Federal
Blanket Purchase Agreement to supply liquid and compressed gas services of contractor-owned gas cylindersThis Blanket Purchase Agreement is issued to secure liquid and compressed gas services through contractor-owned cylinders to ensure a continuous and adequate supply for the Health Effects Laboratory Division at the NIOSH Morgantown Facility in West Virginia. The contractor is also required to provide dry ice, with historical capacity standards indicating a need to maintain up to 300 pounds of dry ice pellets in the designated blue bin on site. The solicitation is a Total Small Business Set-Aside under FAR 19.5, restricting eligibility to small businesses, and is classified under NAICS code 325120 for chemical manufacturing. The contracting activity is managed by the CDC Office of Acquisition Services under the Department of Health and Human Services, with the primary point of contact being Jennifer Gartzke at xuy7@cdc.gov. Amendment 1 extends the deadline for submitting questions to July 16, 2026, and moves the response submission deadline to July 24, 2026, with the original posting date being July 17, 2026. The place of performance is Morgantown, West Virginia, 26505, while the contracting office is located in Atlanta, Georgia. No contract value, pricing details, evaluation criteria, delivery schedules, inspection standards, packaging requirements, or special clauses were provided in the available documentation.
Industrial Gas Manufacturing

POSTED

about 21 hours ago

DEADLINE

in 4 days
View Details
NAICS: 811210
New
Federal
Peak Sci Nitrogen Generator PMAThe Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to Peak International Group Ltd. for an equipment maintenance agreement covering two Peak Scientific Genius XE35 nitrogen gas generators, identified by serial numbers 722100430 and 724060569, which are critical to supporting mass spectrometers and DNA sequencers within the Biotechnology Core Facility Branch. The service contract mandates a Complete Plan 48/72 Service Plan (SL3a-Tier-NA), including on-site service with a maximum 48-hour response time, unlimited parts replacement, engineer labor and travel, priority technical support, and one scheduled preventative maintenance visit per year. Peak Scientific is the sole authorized source for original equipment manufacturer parts and services, as the company does not train, authorize, or support any third-party vendors for maintenance or repair, making competition impossible under federal procurement rules. The procurement is justified under FAR 13.106-1(b)(1)(i) due to the exclusive nature of OEM parts and service authorization. The National Institute of Standards and Technology NAICS code 811210 applies to this requirement. Interested parties must submit a capability statement not exceeding two pages in length, using 10-point font or larger, in Microsoft Word or PDF format, by 12:00 PM Eastern Standard Time on July 22, 2026, exclusively via email to zsm9@cdc.gov. No telephone inquiries or offers will be accepted. The government will evaluate submissions solely to determine whether competitive procurement is feasible or if the sole source award should proceed. The anticipated award date is on or before August 1, 2026, and this notice is not a solicitation for competitive bids.
Electronic and Precision Equipment Repair and Maintenance

POSTED

2 days ago

DEADLINE

in 4 days
View Details
NAICS: 811210
New
Federal
AB SCIEX MDQ PMA PACE MDQ PlusThe Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to AB SCIEX, LLC for an annual preventative maintenance agreement covering the AB SCIEX PACE MDQ Plus Capillary System, serial number B525230047. This procurement is justified under FAR 13.106-1(b)(1)(i) due to the proprietary nature of the system, which includes exclusively manufactured parts and software only available through AB SCIEX, making it the sole provider capable of servicing the equipment. The contractor must deliver comprehensive maintenance services including one annual scheduled preventative maintenance visit with full system diagnostics and critical part replacement, unlimited breakdown calls, and prioritized response within 24 to 48 hours for any failures, covering all labor, travel, and parts required. The solicitation is not open to competitive bidding; however, interested parties must submit a capability statement no longer than two pages, using no smaller than 10-point font, in Microsoft Word or Adobe PDF format to Javier Aponte at zsm9@cdc.gov by 12:00 PM Eastern Standard Time on July 22, 2026. The statement must provide detailed management and technical information along with cost data and verifiable proof of authorized distributor status. Telephone inquiries or submissions will not be accepted. The anticipated award date is on or before August 1, 2026, and the procurement falls under NAICS code 811210 for Electronic and Precision Equipment Repair and Maintenance. All submissions will be evaluated solely to determine whether to proceed with a sole source award or reconsider competition, with the government retaining full discretion over the decision.
Electronic and Precision Equipment Repair and Maintenance

POSTED

2 days ago

DEADLINE

in 4 days
View Details
NAICS: 492110
New
Federal
RFI: Specialized Domestic and International Cold-Chain Logistics Services for the International Reagent Resource (IRR)The Centers for Disease Control and Prevention, through the National Center for Immunization and Respiratory Diseases, is seeking information from commercial logistics providers capable of supporting the domestic and international cold-chain distribution of diagnostic reagents, influenza viruses, molecular detection materials, and other temperature-sensitive biological products used for respiratory pathogen detection. These materials, handled and prepared at the American Type Culture Collection facility in Manassas, Virginia, require strict temperature controls—including refrigerated, frozen, and ultra-low temperature environments—as well as compliance with IATA, ICAO, DOT, and international regulatory standards. The logistics provider must ensure end-to-end chain-of-custody, real-time shipment tracking, validated packaging, and continuous cold-chain monitoring throughout transit, with the ability to respond to excursions and maintain product integrity under demanding conditions. The program also demands robust customs clearance support, import/export documentation assistance, dry ice replenishment during long-haul transit, and customer service available across multiple time zones to facilitate global delivery to public health labs, ministries of health, and research institutions. The request for information seeks detailed capabilities of vendors, including experience transporting biological and medical products, cold-chain infrastructure, temperature ranges supported, monitoring technologies, customs brokerage expertise, and international shipping reach, particularly in support of government and public health entities. Respondents must describe surge capacity for responding to seasonal influenza events or emerging disease outbreaks, quality management systems such as ISO or GDP compliance, IATA Dangerous Goods certifications, and performance metrics for on-time delivery and shipment integrity. The CDC is evaluating market readiness to inform future procurement requirements and is not soliciting bids or pricing at this stage. Responses must be submitted electronically in PDF format within ten pages, and must include both primary and secondary points of contact. The opportunity is open to all qualified providers, with no obligation to issue a contract, and submission is voluntary and at the respondent’s expense.
Couriers and Express Delivery Services

POSTED

3 days ago

DEADLINE

in 28 days
View Details
NAICS: 541715
New
Federal
Notice of Intent to Sole Source - Development and Validation of Diagnostic Methods for Coccidioidomycosis (Valley Fever)The Centers for Disease Control and Prevention intends to award a sole source firm fixed price contract to Valley Fever Solutions, INC, through the Valley Fever Center for Excellence at the University of Arizona, to develop, evaluate, and validate diagnostic methods for coccidioidomycosis, commonly known as Valley Fever. The project will utilize the center’s established biospecimen repository and clinical infrastructure to advance diagnostic assays, with additional specimen collection and enhanced storage capacity being implemented to meet expanded research demands. All work will be conducted exclusively at the Valley Fever Center for Excellence in Tucson, Arizona, with no performance occurring at CDC facilities. The contract is classified under Product or Service Code AN12 for Health R&D Services and NAICS Code 541715 for Research and Development in the Life Sciences, with a performance period spanning from September 30, 2026, to September 29, 2027. This procurement is being conducted under the authority of FAR 13.106-1(b) and 10 U.S.C. 2304(c)(1), allowing for non-competitive award due to the unique expertise and existing infrastructure of the Valley Fever Center for Excellence. Although this is a notice of intent for a sole source acquisition and not a competitive solicitation, interested parties may submit responses by 11:00 AM Eastern Time on July 29, 2026, to dwb7@cdc.gov. The government retains full discretion to determine whether competition will be pursued based on responses received. The contract is designated as a total small business set-aside, and all correspondence and submissions must be directed to the primary point of contact, Marquetta Taylor, at the CDC Office of Acquisition Services in Atlanta, Georgia.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

3 days ago

DEADLINE

in 11 days
View Details